Q0177 Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen
Short descriptor: Hydroxyzine pamoate 25mg
Look up Q0177 alongside ICD-10-CM diagnoses, the HCPCS Table of Drugs, and the AI coding assistant.
Q0177 is the HCPCS Level II code for Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen (2026). It belongs to Section Q — Temporary Codes. Under Medicare, its coverage status is: Special coverage instructions apply. Part B pricing methodology: Drugs.
Classification & CMS Attributes
- Section
- Q: Temporary Codes
- Medicare Coverage
- Special coverage instructions apply (code D)
- Part B Pricing
- Drugs (indicator 51)
- Type of Service
- Medical care
- Effective Date
- 1998-04-01
- 2026 Maintenance
- No change this year
References
Cite This Page
Reference Q0177 with the canonical source and edition:
Q0177 — Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen. ICD-10 Coding Pro (HCPCS Level II 2026). https://icd10codingpro.com/hcpcs-codes/Q0177
Canonical URL: https://icd10codingpro.com/hcpcs-codes/Q0177